VNVALUEVNVALUE
Updated weekly
Back to Dashboard
Consumer sector

UPH

Consumer
Công ty Cổ phần Dược phẩm TW25
Y tế/Dược phẩmCT
4.600
VND · Last close
Valuation Verdict
Undervalued
Low
-120%Fair Value+120%
Intrinsic Value
15.931
Current
4.600
Gap
+246.3%
ModelFCF DCF

Valuation Breakdown

CTY tếConsumer
Classified as consumer because ICB sector "Y tế" maps to the consumer group
ModelFCF-Based DCF
Value = Sum of [FCF / (1+WACC)^t] + Terminal Value / (1+WACC)^n

A classic Discounted Cash Flow model built on Free Cash Flow (FCF), the actual cash a business generates after all operating expenses and capital expenditures. Future FCF is projected for 10 years with gradually decaying growth, then discounted back to today's value using WACC. This is the gold standard of intrinsic valuation: it values the company based on what it can actually deliver to shareholders, independent of market sentiment.

1
Weighted Avg Cost of Capital
Risk-Free (Rf)
4.50%
+
Betasector default
0.800
x
ERP
4.25%
+
CRP
2.75%
=
Cost of Equity (Ke)
10.10%
Ke
10.10%
x
E/(D+E)
40.61%
+
Kd(1-t)
6.94%
x
D/(D+E)
59.39%
=
WACC
10.00%
2
Growth Estimate
Sector Default4.00%
Growth decays 10%/yr toward terminal
3
Model Inputs
Base FCF9.37B
Projection years10
4
Valuation
Base FCF
9.37B
Growth Rate
4.00%
WACC
10.00%
Terminal Growth
4.00%
DCF Value
15.931
Value Decomposition
43%
57%
Explicit period (43%)Terminal value (57%)

Valuation Track Record

Retroactive intrinsic value vs actual close price — UPH

Earnings Quality

Fiscal year 2025

72
Good
Accrual Quality
92
Cash Conversion
100
Receivables
3
Margin Stability
71
Revenue Quality
85

Financial Forensics

Beneish M-Score · 2025

-2.68
Low Risk
DSRI
0.993
GMI
1.020
AQI
0.998
SGI
0.865
DEPI
1.022
SGAI
0.977
TATA
-0.020
LVGI
0.992

UPH exhibits a Beneish M-Score of -2.6835, indicating a low likelihood of earnings manipulation. The earnings quality score of 71.9/100, particularly strong cash conversion metrics, suggests a solid financial foundation despite some minor concerns in receivables management.

Red Flags
  • The receivables quality score is only 2.9/100, indicating potential issues in collecting receivables, which could impact cash flow.
  • The company's growth index (SGI) at 0.8650 suggests a decline in revenue growth, which may raise concerns about future performance.
Positive Signals
  • The earnings quality score of 71.9/100, particularly with a cash conversion score of 100.0/100, indicates strong operational efficiency and effective cash management.
  • The low DSRI of 0.9927 suggests that inventory levels are well managed relative to sales, reducing the risk of overstocking.
Ownership Risk

The ownership structure is heavily concentrated, with institutional shareholders holding 86.5% of the company. This concentration can lead to stability in decision-making but may also pose risks if these entities prioritize their interests over minority shareholders.

Recommendation

Monitor the receivables closely due to the low score, and consider engaging with management to understand their strategies for improving revenue growth. Given the strong cash conversion, the stock may be a stable investment in the short term.

Generated by AI based on quantitative data. Not financial advice.

Quantitative Scores

F-Score
4/9
Neutral
Z-Score
0.87
Distress Zone
Sharpe
-0.22
Negative
Composite
83
Strong
Price Risk
Momentum
+36.8%
Volatility
124.6%
Max Drawdown
-51.2%

Key Ratios

Fiscal year 2025
41.09P/E
P/B0.59
P/S0.82
ROE1.4%
ROA0.6%
EPS170.37
BVPS11840.64
Gross Margin12.8%
Net Margin2.0%
D/E1.46
Current Ratio1.32
Rev Growth-13.2%
Profit Growth-26.2%
EV/EBITDA15.85
Div Yield0.0%

Company Overview

Issued Shares
13.3M
Charter Capital
132.9B VND
Sector (ICB L2)
Y tế
Industry (ICB L3)
Dược phẩm
Sub-industry
Dược phẩm
Company Type
CT

// OWNERSHIP_NETWORK

> mapping common ownership for UPH — hover nodes for intel, click to navigate

Shareholders
Công ty Cổ phần Dược Phẩm OPC
Inst
58.1%
7.7 trieu
Tổng Công ty Dược Việt Nam
Inst
28.4%
3.8 trieu
Lê Thị Ánh Nguyệt
Indiv
0.1%
13.436
Board & Management
Đặng Quốc Việt
Thành viên Ban kiểm soát
Trịnh Việt Tuấn
Thành viên Hội đồng Quản trị/Tổng Giám đốc
Ngô Tân Long
Phó Tổng Giám đốc
Nguyễn Văn Khái
Thành viên Ban kiểm soát
Trịnh Xuân Vương
Thành viên Hội đồng Quản trị
Đặng Hoài Nam
Phụ trách Công bố thông tin
Nguyễn Thị Hồng Nga
Phó Tổng Giám đốc Kỹ thuật
Trần Anh Vương
Thành viên Hội đồng Quản trị
Tống Trần Hiệp
Thành viên Hội đồng Quản trị/Kế toán trưởng
Trịnh Thị Minh
Trưởng Ban kiểm soát
Computed 12/04/2026
Methodology & Disclosure

vnvalue is a methodology engine — not an advisor. Every number is the deterministic output of a published formula applied to public financial data. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →